Schlumberger (SLB) Stock Sinks As Market Gains: What You Should Know

Schlumberger (SLB) shares have declined 9.55% over the past month, underperforming the broader market and the Oils-Energy sector. Despite this, the company faces positive analyst sentiment with recent upward estimate revisions, forecasting a 14.1% increase in quarterly EPS to $0.89 and an 11.96% rise in revenue to $9.3 billion, alongside double-digit growth projections for the full year. SLB is currently valued at a discount to its industry peers, trading at a Forward P/E of 11.35 and a PEG ratio of 0.84, holding a Zacks Rank #3 (Hold) within an industry ranked in the bottom 30%.

Analysis

Schlumberger (SLB) presents a clear divergence between its recent market performance and its forward-looking fundamental outlook. The stock has significantly underperformed, declining 9.55% over the last month, which is a steeper loss than its Oils-Energy sector's 4.22% decline and starkly contrasts with the S&P 500's 2.92% gain. Despite this negative price momentum, analyst expectations for the upcoming earnings report are robust, forecasting a 14.1% year-over-year increase in EPS to $0.89 and an 11.96% rise in revenue to $9.3 billion. This optimism extends to the full year, with consensus estimates projecting double-digit growth in both earnings (+17.11%) and revenue (+11.29%). From a valuation perspective, SLB appears attractive, trading at a Forward P/E of 11.35, a considerable discount to the industry average of 15.57. Furthermore, its PEG ratio of 0.84 is below the industry's 0.91, suggesting the stock may be undervalued relative to its expected growth rate. However, this positive fundamental and valuation picture is tempered by a Zacks Rank of #3 (Hold) and the company's position within a poorly ranked industry, which falls in the bottom 30% of over 250 industries, indicating potential sector-wide headwinds.

Key Decisions for Investors

• Investors with a value-oriented approach might consider the recent 9.55% stock price decline as a potential entry point, given the company's strong double-digit growth forecasts and its discounted valuation relative to peers.
• Caution is warranted due to the stock's significant market underperformance and its placement in a weak industry group; the upcoming earnings release will be a critical catalyst to either validate the bullish growth thesis or confirm the market's bearish sentiment.
• Monitor for any further positive analyst estimate revisions, as the source material suggests these are directly correlated with near-term stock movements and could signal a turning point for the stock ahead of earnings.